Home » Topics » Conferences

Conferences
RSS

First patients being treated with bombesin/GRP antagonist RC-3095

June 25, 1998

Cationic peptides exert selective antitumor activity against sensitive and resistant cell lines

June 25, 1998

CMB-401, an immunoconjugate for the targeted treatment of EOC

June 25, 1998

Anthracenedione analogue BBR-2778 moves to phase I testing

June 25, 1998

Positive phase II results for GMK vaccine presented at NCI-EORTC meeting

June 25, 1998

Potent angiogenesis inhibitor AG-3340 profiled at NCI-EORTC symposium

June 24, 1998

Phase II evaluation of carzelesin in NHL

June 24, 1998

Miproxifene phosphate, a promising treatment for breast cancer

June 24, 1998

Management strategy including hydroxyurea successful in unresectable meningioma

June 24, 1998

S-16020-2: a topoisomerase II inhibitor selective for renal cancers heads for phase II testing

June 24, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...